Selective omission of level V nodal coverage for patients with oropharyngeal cancer: Clinical validation of intensity-modulated radiotherapy experience and dosimetric significance.
Pranshu MohindraErich UrbanJonathan D PaganHeather M GeyeVatsal B PatelR Adam A BaylissEdward T BenderPaul M HarariPublished in: Head & neck (2015)
We clinically validate the consensus recommendation for selective omission of level V nodal coverage in IMRT planning of patients with oropharyngeal cancer and demonstrate significant dosimetric advantages.